Circulation publishes Benestent II pilot results
This article was originally published in Clinica
Heparin-coated stents are 99% effective in opening coronary arteries without clotting complications, according to results from the Benestent II pilot study published in the American Heart Association journal Circulation, this month. Stent thrombosis was 3.5% in Benestent I, the trial of the uncoated Palmaz-Schatz stent. The pilot study results, were first presented at the European Society of Cardiology meeting in Amsterdam in August 1995 (see Clinica No 669/70, p 24).
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.